Hemant C. Email and Phone Number

- Prepare Product pipeline, Business Case preparation of the entire product portfolio including commercialized, products under development.- Facilitating Project go/no go decisions prompting discussion’s due to change in market dynamics, competitive situation- Understanding the market dynamics and developing revenue and costing model of the project- Active role in providing R&D, Manufacturing with market requirements such as volume projections, batch sizes, pack sizes, trade dress, development inputs- Identifying new potential growth areas for formulation such as limited competition products , Bio waiver, Complex Gx- Developing revenue and costing model of the project, preparing business cases / NPV analysis for products- Analysis and Sales estimation of the product opportunities coming from In-licensing team.- Responsible for market analysis through secondary research with IMS Sales data, Orangebook, Drugs@fda- Review the market dynamics and developments across industry and their impact on the current and future business.-Manage and drive Monthly market updates slides, based on existing IMS data feeds and Internal Data, orange book, Drugs@fda etc.

- Proficient in Business Modelling- Developing and reviewing business models for new product evaluation for US Generics market – Building assumptions and scenarios for strategic decision making.- Evaluate time and cost over-run projects for evaluating financial viability for go/no go decisions.- Well-versed with IMS data analysis – pricing, market share, sales growth & other metrics.- Evaluation of sales forecast; financials of new products.- Complete analysis and evaluation of the current, existing and pipeline portfolio.- Evaluation of products using NPV/IRR analysis.- Close coordination with Project management & R&D teams for evaluation of projects in pipeline.

- Close coordination with Project management & R&D teams for evaluation of projects in pipeline.- Monitoring of project cost & strategic planning for oral solid dosage.- Evaluate time and cost over-run projects for evaluating financial viability for go/no go decisions.- Review and analysis of monthly forecast of revenue expenditure of R&D verticals.Evaluating financial viability of identified products in supporting DF Development Initiation activity.

- Review of products based on business development inputs for pricing, market share, and cost benefit analysis.- Manage and drive monthly market updates, based on existing IMS data feeds and Internal Sales Data.- Support Business Development/Portfolio team with timely evaluation of new products and its financial feasibility.- Agreement management - working with the offshore SBU Business Development team in maintaining agreement masters with customers, invoicing & collections responsibilities.- Analysis and evaluation of the current, existing and pipeline portfolio.- NPV analysis - Evaluation of out licensing /in- licensing opportunities and proposals with Portfolio/ BD team.- Preparing new product costing & margin analysis. This involved analysis for in-house vs. outsource API and formulation (product) development.

- Directly worked with portfolio team for screening/evaluation of new products for various geographies and prepare the global product grid ophthalmic suspension & solution drops.- Closely worked with Portfolio Team in defining entry strategy for new segments like ophthalmic ointments and inhalation products. - Periodic portfolio review with Marketing and R&D to review projections, competitive dynamics, prioritization/re-prioritization.- Presented 5-year revenue and profitability plan from the existing and pipeline portfolio.

- Designed and implemented R&D Product Cost Monitoring framework with E&Y capturing and allocation of all R&D center’s overheads to product level.- Active role in providing R&D, Manufacturing with market requirements such as volume projections, batch sizes, pack sizes, trade dress, development inputs.- Business Intelligence – Laid down process, validation and integration of R&D MIS through BI tool